Answers are grounded in this paper and cite their sources.
A new diketopiperazine, hoynatamide (1), together with six known analogues 2–7, was isolated from the marine sediment-derived bacterium Streptomyces hoynatensis Veyisoglu and Sahin S-1412ᵀ (=KCTC 29097 = DSM 42069). The structure of hoynatamide was elucidated through comprehensive spectroscopic analyses, including 1D and 2D NMR, HR-ESI-MS, IR, and Marfey’s method. Among the isolated compounds, 2 and 3 exhibited the strongest cytotoxic effects against HeLa and MCF-7 cells, with IC50 values of 19.4 and 32.4 µM, respectively, while compound 1 showed only weak cytotoxicity. Compounds 2–5 showed no measurable cytotoxicity towards non-cancerous MEF cells under the tested conditions. In antimicrobial assays, all compounds showed weak antibacterial activity against Escherichia coli (MIC = 128 µg/mL), whereas compounds 2–7 showed weak antifungal activity against Candida albicans (MIC = 64 µg/mL).
No takes yet. Share an insight, caveat, or question.
Coskun et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: